Evidence map›Paper›PMID 39056827›Full record

ReviewBiomimetics (Basel, Switzerland)2024

The Impact of Nano-Hydroxyapatite Scaffold Enrichment on Bone Regeneration In Vivo-A Systematic Review.

Dijana Mitić, Jelena Čarkić, Jelena Jaćimović, Miloš Lazarević, Milica Jakšić Karišik, Boško Toljić, Jelena Milašin

Abstract readReview
In one paragraph

Review in Biomimetics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dijana MitićSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-0650-8193
Jelena ČarkićSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-1014-7589
Jelena JaćimovićSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6537-7269
Miloš LazarevićSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1330-5332
Milica Jakšić KarišikSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1114-0829
Boško ToljićSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6664-2829
Jelena MilašinSchool of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6225-7210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn order to ensure improved and accelerated bone regeneration, nano-hydroxyapatite scaffolds are often enriched with different bioactive components to further accelerate and improve bone healing. In this review, we critically examined whether the enrichment of nHAp/polymer scaffolds with growth factors, hormones, polypeptides, microRNAs and exosomes improved new bone formation in vivo. MATERIALS AND

methodsOut of 2989 articles obtained from the literature search, 106 papers were read in full, and only 12 articles met the inclusion criteria for this review.

resultsSeveral bioactive components were reported to stimulate accelerated bone regeneration in a variety of bone defect models, showing better results than bone grafting with nHAp scaffolds alone.

conclusionsThe results indicated that composite materials based on nHAp are excellent candidates as bone substitutes, while nHAp scaffold enrichment further accelerates bone regeneration. The standardization of animal models should be provided in order to clearly define the most significant parameters of in vivo studies. Only in this way can the adequate comparison of findings from different in vivo studies be possible, further advancing our knowledge on bone regeneration and enabling its translation to clinical settings.

Indexed as

bioactive componentsbone scaffoldnano-hydroxyapatiteregenerationtissue engineering

Identifiers

PMID39056827
PMCPMC11274561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.